Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer
Status:
Withdrawn
Trial end date:
2022-02-25
Target enrollment:
Participant gender:
Summary
This randomized phase IV trial studies how well the continuous infusion of ropivacaine
hydrochloride works in reducing pain after surgery in patients with bladder cancer.
Ropivacaine hydrochloride is an anesthetic drug used to decrease pain by numbing an area of
the body without putting the patient to sleep. Continuous infusion of ropivacaine
hydrochloride may reduce pain and improve the quality of life for patients after bladder
surgery.